Icon
+91 94997 68112
Login Register

Kisqali Femara Co-Pack - (200 mg and 2.5 mg, Tablet)

Ribociclib Succinate and Letrozole (Copackaged) Novartis
200 mg and 2.5 mg, Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
None
Less Than 5
None None
KISQALI FEMARA CO-PACK, a co-packaged product containing ribociclib, a kinase inhibitor, and letrozole, an aromatase inhibitor, is indicated as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
Yes
******** **** ********* **** (*** ** * ***) ** **** **, **** ** ******* ** '***, '***, '***, '***, '***, '***, '*** *** '***. ******** **** *** *** (*** ** * *** ******) ** **** **, **** ** ******* ** '***, '***, '***, '*** *** '***.
Kisqali Femara Co-Pack Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
********* **** ******* ******* ******* ******* ******* ******* ******* *******
*** **** **** ** **** **, **** **** ** **** **, **** **** ** **** **, **** **** ** **** **, **** *** ********* **** ** **** **, **** *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
********* **** *** \ ********* *** **, **** ******* **** ******* *** **** *** *** ****
*** **** *** \ *** *** **, **** ******* ********* ******** *** ****** *** ****
  1. *** **, **** : * ****-** ** ***** *** ***** *** **** *** *********.
  2. *** **, **** : ******** **** ********* **** ******* ** '***, '***, '***, '***, '***, '***, '*** *** '***.
  3. *** *, **** : ******** **** *** *** ** ******* ** '***, '***, '***, '*** *** '***.
  4. *** **, **** : ******** *** ********* ******* ********** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.